MBP is a CNS autoantigen in MS and MBP89-98 is one of the encephalitogenic epitopes of MBP that can be recognized by myelin-reactive T cells in the context of MHCII HLA-DR2a antigen presentation. The gene discussed is MBP; the disease is myeloid sarcoma.